Dr. Cristina Richie, Lecturer in Ethics of Technology, Department of Philosophy, Edinburgh University Future’s Institute, looks at the ethical considerations raised by the environmental impact of “digital twins”. Technology has revolutionised health care. As medicine and science intersect, more heal
Apreo Health, a clinical-stage medical device company developing a novel treatment for severe emphysema, has announced the closing of an oversubscribed 130 million USD Series B financing round. The financing was co-led by new investors Bain Capital Life Sciences and Norwest, with participation from
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, and advisor to MedTech suppliers, reports on a new review of the supply of continence products. NHS England is undertaking a review of the current processes and commercial mo
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, and advisor to MedTech suppliers, reports on a call for potential VBP pilots to be urgently identified. The UK’s Department of Health and Social Care has called for potential
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, and advisor to MedTech suppliers, records World Health Organization recognition for UK’s medical device regulator. The World Health Organization (WHO) has recognised the UK’s
In 1995 the FDA approved the first AI-enabled medical device, an automatic interactive gynaecological instrument to analyse Papanicolau (PAP) cervical smears. Although the FDA has been reviewing and authorising AI-enabled devices for 30 years, for most of that time these devices were a relative rari
CereVasc, Inc., a clinical-stage, medical device company developing novel treatments for neurological diseases, has announced that the 100th patient has received treatment for communicating hydrocephalus with the eShunt System. The 100 patients were enrolled in pilot studies and in the STRIDE clinic
Cardiosense, a medical AI company transforming cardiovascular disease management has announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the CardioTag device, the first multimodal, wearable sensor that simultaneously captures high-fidelity electrocardiogram (E
Glasgow-based company CardioPrecision has successfully executed the first clinical cases of robotic aortic valve replacement through a tiny incision in the neck. Last year, the global leader in transcervical access for the treatment of structural heart disease demonstrated a proof-of-concept AVATAR
Sanome, a company building Clinical Decision Support tools to detect emerging health risks, has secured Class IIb CE certification and MHRA approval for MEMORI – an AI-enabled warning system for the early prediction/prevention of healthcare‑associated infections (HAIs) – at the same time as appointi
Samuel Bateman is a senior associate and patent attorney, and Chris Froud is a partner and patent attorney, at European IP firm, Withers & Rogers. Both specialise in advising innovative companies and developers in electronics and computing. The combination of enhanced imaging technologies and AI-pow
Sony Healthcare Solutions Europe and Siemens Healthineers have announced a strategic global collaboration that combines ARTIS, the high-end angiography system of Siemens Healthineers, with Sony’s cutting-edge NUCLeUS audio-visual management platform. Through the strategic alliance, the ARTIS systems
